Search results for "must"

showing 10 items of 340 documents

Combined Carboplatin plus Ifosfamide and Cisplatin in Patients with Advanced Ovarian Carcinoma. A Phase I–II Study

1998

Abstract Because of the relative lack of overlapping toxicity, carboplatin (PPL) and cisplatin (CDDP) can be easily combined for treatment of ovarian cancer to increase total platinum dose intensity. Ifosfamide (IFO), one of the most effective single agents in ovarian cancer, has a low hematological toxicity when administered in continuous infusion. From January 1991 to December 1993, 34 patients with advanced ovarian cancer, previously untreated with chemo- or radiotherapy, were enrolled in a phase I–II study with the aim of determining the maximum tolerated dose (MTD) of CDDP (on day 8 of a 28-day cycle) in combination with PPL (300 mg/m 2 on day 1) and IFO (4,000 mg/m 2 /24 h by continuo…

Cisplatinmedicine.medical_specialtyChemotherapyIfosfamidebusiness.industrymedicine.medical_treatmentUrologyObstetrics and GynecologyPhases of clinical researchmedicine.diseaseNitrogen mustardCarboplatinSurgerychemistry.chemical_compoundOncologychemistryToxicitymedicinebusinessOvarian cancermedicine.drugGynecologic Oncology
researchProduct

Alkali consumption of aliphatic carboxylic acids during alkaline pulping of wood and nonwood feedstocks

2013

Abstract The carbohydrate degradation products have been examined, which are formed during the conventional kraft pulping of a softwood, hardwoods, bamboo, and wheat straw as well as soda and soda-anthraquinone pulping of wheat straw. The focus was on “volatile” acids such as formic and acetic acids and “nonvolatile” hydroxy monocarboxylic and dicarboxylic acids. The different consumption profiles were obtained for the charged alkali required for the neutralization of these aliphatic acids depending on the feedstock and the cooking method. The relative composition of the acid fraction in the black liquors of softwood and hardwood and nonwood feedstocks showed characteristic variations. Howe…

Consumption (economics)bambooBambooSoftwooddeacetylationwheat strawChemistryaliphatic carboxylic acidsalkaline pulpinghardwoodfood and beveragesmustalipeäAlkali metalPulp and paper industrycomplex mixturesBiomaterialsstomatognathic diseasesstomatognathic systemsoftwoodBotanyHardwoodBlack liquorhfsg
researchProduct

Parallel Publishing from Converis to DSpace Using Custom Export and REST API

2018

Presentation in the CRIS 2018 conference in Umeå, Sweden, June 14 - 16, 2018

ConverisCRISjulkaisuarkistottutkimustietojärjestelmätrinnakkaisjulkaiseminenDSpacerepositories
researchProduct

Black Hole Shadow Drift and Photon Ring Frequency Drift

2021

The apparent angular size of the shadow of a black hole in an expanding Universe is redshift-dependent. Since cosmological redshifts change with time - known as the redshift drift - all redshift-dependent quantities acquire a time-dependence, and a fortiori so do black hole shadows. We find a mathematical description of the black hole shadow drift and show that the amplitude of this effect is of order $10^{-16}$ per day for M87$^{\star}$. While this effect is small, we argue that its non-detection can be used to constrain the accretion rate around supermassive black holes, as well as a novel probe of the equivalence principle. If general relativity is assumed, we infer from the data obtaine…

Cosmology and Nongalactic Astrophysics (astro-ph.CO)General relativityAstrophysics::High Energy Astrophysical PhenomenasuhteellisuusteoriaFrequency driftFOS: Physical sciencesmustat aukotGeneral Relativity and Quantum Cosmology (gr-qc)Astrophysics::Cosmology and Extragalactic AstrophysicsAstrophysicskosmologiaGeneral Relativity and Quantum CosmologyGeneral Relativity and Quantum CosmologyavaruustutkimusfysiikkaEvent Horizon TelescopePhysicsSupermassive black holemaailmankaikkeusOrder (ring theory)Coupling (probability)varjotRedshiftBlack holeavaruusvaloAstrophysics - Cosmology and Nongalactic AstrophysicsThe Open Journal of Astrophysics
researchProduct

Shining primordial black holes

2021

We study the well-motivated mixed dark matter (DM) scenario composed of a dominant thermal WIMP, highlighting the case of $SU(2)_L$ triplet fermion "winos", with a small fraction of primordial black holes (PBHs). After the wino kinetic decoupling, the DM particles are captured by PBHs leading to the presence of PBHs with dark minihalos in the Milky Way today. The strongest constraints for the wino DM come from the production of narrow line gamma rays from wino annihilation in the Galactic Center. We analyse in detail the viability of the mixed wino DM scenario, and determine the constraints on the fraction of DM in PBHs assuming a cored halo profile in the Milky Way. We show that already wi…

Cosmology and Nongalactic Astrophysics (astro-ph.CO)Milky WayAstrophysics::High Energy Astrophysical PhenomenaastrofysiikkaDARK-MATTER ANNIHILATIONFOS: Physical sciencesmustat aukotPrimordial black holeAstrophysicsGeneral Relativity and Quantum Cosmology (gr-qc)Astrophysics::Cosmology and Extragalactic Astrophysicskosmologia7. Clean energy01 natural sciences114 Physical sciencesGeneral Relativity and Quantum Cosmologypimeä aineHigh Energy Physics - Phenomenology (hep-ph)WIMP0103 physical sciences010306 general physicsAstrophysics::Galaxy AstrophysicsPhysicsHigh Energy Astrophysical Phenomena (astro-ph.HE)Annihilation010308 nuclear & particles physicsGalactic CenterGAMMA-RAYSCONSTRAINTSFermionHigh Energy Physics - PhenomenologyMixed dark matterMILKYHaloAstrophysics - High Energy Astrophysical PhenomenaAstrophysics - Cosmology and Nongalactic Astrophysics
researchProduct

Axion star nucleation in dark minihalos around primordial black holes

2020

We consider a general class of axion models, including the QCD and string axion, in which the PQ symmetry is broken before or during inflation. Assuming the axion is the dominant component of the dark matter, we discuss axion star formation in virialized dark minihalos around primordial black holes through gravitational Bose-Einstein condensation. We determine the conditions for minihalos to kinetically produce axion stars before galaxy formation. Today, we expect up to $\sim 10^{17}$ ($\sim 10^9$) axion stars in a radius of 100 parsecs around the Sun for the case of the QCD (string) axion.

Cosmology and Nongalactic Astrophysics (astro-ph.CO)Physics::Instrumentation and DetectorsDark matterFOS: Physical sciencesmustat aukotPrimordial black holeGeneral Relativity and Quantum Cosmology (gr-qc)Astrophysics::Cosmology and Extragalactic AstrophysicsAstrophysicshiukkasfysiikka01 natural sciencesGeneral Relativity and Quantum CosmologyGravitationHigh Energy Physics::TheoryHigh Energy Physics - Phenomenology (hep-ph)0103 physical sciencesGalaxy formation and evolution010306 general physicsAxionAstrophysics::Galaxy AstrophysicsPhysicsInflation (cosmology)010308 nuclear & particles physicsStar formationHigh Energy Physics::PhenomenologyHigh Energy Physics - PhenomenologyStarsydinfysiikkaAstrophysics - Cosmology and Nongalactic AstrophysicsPhysical Review D
researchProduct

JYU-malli : keskitetty julkaisutiedonkeruu Jyväskylän yliopistossa

2020

Kuusi vuotta on kulunut siitä, kun Jyväskylän yliopisto siirtyi julkaisutietojen keskitettyyn tallentamiseen. Aiemmin hajautetusti tutkijoiden omasta toimesta tapahtunut CRIS-kirjaamistyö siirrettiin kirjaston (nyk. Avoimen tiedon keskus, OSC) vastuulle niin, että tutkijat itse eivät kirjauksia enää tee, vaan niistä huolehtii OSC. Syntyi "JYU-malli". Tässä artikkelissa kerrotaan, mikä JYU-malli on, miten se toimii ja mitä tuloksia sillä on saavutettu. nonPeerReviewed

Current Research Information System (CRIS)työprosessittutkimustoimintatieteellinen julkaisutoimintatietojärjestelmättiedontallennus
researchProduct

Observations on the effects of cyclophosphamide, phosphoramide mustard and some activated oxazaphosphorines on murine L1210 leukemia.

1984

The L1210 tumor system was used in vitro and in vivo in comparative studies with activated cyclophosphamide analogs, cyclophosphamide and phosphoramide mustard. All the above compounds gave substantial cell kills (5 logs) of L1210 in vivo at doses that were non-toxic, but slight differences were noted. ASTA Z 7557 had a slight advantage in cure rate over cyclophosphamide when these drugs were given i.v. or i.p. to early tumor (i.p.). However, cyclophosphamide had the advantage in cure rate when drug administration was i.v. to advanced tumor. At equimolar concentrations in vitro ASTA Z 7557 was more cytotoxic than either phosphoramide mustard or acrolein. In vivo, the activated cyclophospham…

CyclophosphamideCell SurvivalPharmacologychemistry.chemical_compoundMiceFibrosisIn vivomedicineAnimalsPharmacology (medical)Clonogenic assayLeukemia L1210CyclophosphamideTumor Stem Cell AssayPharmacologyMice Inbred BALB CDose-Response Relationship Drugbusiness.industryAcroleinTumor Stem Cell Assaymedicine.diseasePhosphoramide MustardIn vitroOncologychemistryMice Inbred DBAPhosphoramide Mustardsbusinessmedicine.drugInvestigational new drugs
researchProduct

Induction of DNA crosslinks and DNA strand lesions by cyclophosphamide after activation by cytochrome P450 2B1

1997

Cyclophosphamide requires metabolic activation by cytochrome P450 to exert its genotoxic effects. Therefore in vitro studies on its mechanism of action have been limited to the use of self-activating derivatives of cyclophosphamide or to hepatocytes as an activating system. In this study we used a cell line of Chinese hamster lung fibroblasts (V79 cells), genetically engineered to express active cytochrome P450 2B1 as the sole observable cytochrome P450 (SD1 cells). An increase in DNA strand lesions (SL: DNA single-strand breaks and alkali labile sites) was observed between 0.5 and 1.5 mM cyclophosphamide (24 h incubation) which could be classified as alkali labile sites using a modified al…

DNA RepairCyclophosphamideDNA repairDNA damageHealth Toxicology and MutagenesisHamsterBiologyTransfectionCell LineCricetulusCytochrome P-450 Enzyme SystemCricetinaeGeneticsmedicineAnimalsCyclophosphamideMolecular BiologyIncubationBiotransformationDose-Response Relationship Drug4-HydroxycyclophosphamideDNAPhosphoramide MustardBiochemistryCell culturePhosphoramide MustardsDNA Damagemedicine.drugMutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
researchProduct

The Translesion Polymerase Rev3L in the Tolerance of Alkylating Anticancer Drugs

2009

Temozolomide and fotemustine, representing methylating and chloroethylating agents, respectively, are used in the treatment of glioma and malignant melanoma. Because chemoresistance of these tumors is a common phenomenon, identification of the underlying mechanisms is needed. Here we show that Rev3L, the catalytic subunit of the translesion DNA polymerase zeta, mediates resistance to both temozolomide and fotemustine. Rev3L knockout cells are hypersensitive to both agents. It is remarkable that cells heterozygous for Rev3L showed an intermediate sensitivity. Rev3L is not involved in the tolerance of the toxic O6-methylguanine lesion. However, a possible role of Rev3L in the tolerance of O6-…

DNA damageApoptosisDNA-Directed DNA PolymeraseBiologyNitrosourea CompoundsCell LineMiceOrganophosphorus CompoundsREV3LTemozolomidemedicineAnimalsAP siteAntineoplastic Agents AlkylatingPolymeraseMice KnockoutPharmacologyTemozolomideBase excision repairFlow CytometryMolecular biologyDNA-Binding ProteinsDacarbazineMicroscopy FluorescenceCancer researchbiology.proteinMolecular MedicineFotemustineDNA mismatch repairDrug Screening Assays AntitumorDNA Damagemedicine.drugMolecular Pharmacology
researchProduct